|Save ComparisonClear all|
Corium is a commercial-stage biopharmaceutical company leading the development of new transdermal healthcare products.
Alkermes is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system diseases.
MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops and commercializes branded prescription products designed to improve quality of care and address unmet medical needs.
Pulmatrix develops inhaled therapies for the treatment, prevention, and transmission of infectious and progressive respiratory diseases.
Menlo Park, US HQ
Dublin, IE HQ
Rockville, US HQ
South San Francisco, US
Nashville, US HQ
Lexington, US HQ
Valuation ($)386.6 m
Valuation ($)7.5 b
Valuation ($)868.4 m
Valuation ($)109.8 m
Valuation ($)35.2 m
Revenue (est.)$31.9m (FY, 2017)
Revenue (est.)$745.7m (FY, 2016)
Revenue (est.)$157.7m (FY, 2017)
Revenue (est.)$41.2m (FY, 2017)
Revenue (est.)$335k (FY, 2017)
Net income($208.4m) (FY, 2016)
Net income($19.6m) (FY, 2017)
Net income($8m) (FY, 2017)
Net income($18.1m) (FY, 2017)